Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis;Serebral venöz tromboz geçiren hastaların trombofilik risk faktörleri açisından deǧerlendirilmesi

Turkish Journal of Hematology

Volumn 27, Issue 3, 2010, Pages 162-167

  Yokşu, Osman ^a   Balçik, Özlem Şahin ^b   Albayrak, Murat ^c   Ceran, Funda ^d   Daǧdaş, Simten ^d   Yilmaz, Mesude ^d   Özet, Gülsm ^d  

^a Sema Hastanesi Istanbul   (Turkey)

^b FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^c DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cerebral venous thrombosis; Thrombophilia; Thrombophilic defects

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK FACTOR; THROMBOPHILIA;

EID: 78449266129     PISSN: 13007777     EISSN: 13085263     Source Type: Journal    
DOI: 10.5152/tjh.2010.23     Document Type: Article

References (30)

1. Esmon CT. Protein C. The regulation of natural anticoagulant pathways. Science 1987;235:1348-1352.
2. Rosendaal FR. Venous thrombosis, a multicausal disease. Lancet 1999;353:1167-1173.
3. Friedman KD, Rodgers GM. Thrombosis and antithrombotic therapy. In: Greer J P, Foerster J, Lukens J, Rodgers G, Paraskevas F, Glader B, editors. Wintrobe's Clinical Hematology. 11th ed. USA: Lippincott Williams & Wilkins, 2004: 1713-1728.
4. Majluf-Cruz A, Moreno-Hernandez M, Ruiz-de-Chavez-Ochoa A, Monroy-Garcia R, Majluf-Cruz K, Guardado-Mendoza R, Molina-Avila I, Isordia-Salas I, Corona-de la Peña N, Vargas-Vorackova F, Vela-Ojeda J, García-Chávez J. Activated protein C resistance and factor V Leiden in Mexico. Clin Appl Thromb Hemost 2008;14:428-437.
5. Okumus G, Kiyan E, Arseven O, Tabak L, Diz-Kucukkaya R, Unlucerci Y, Abaci N, Unaltuna NE, Issever H. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost 2008;14:168-173.
6. Kovac M, Mikovic D, Antonijevic N, Rakicevic L, Djordjevic V, Radojkovic D, Elezovic I. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population. J Thromb Thrombolysis 2008;25:284-287.
7. Kabukcu S, Keskin N, Keskin A, Atalay E. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey. Clin Appl Thromb Hemost 2007;13:166-171.
8. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res 1997;87:377-385.
9. Kawamoto R, Kohara K, Oka Y, Tomita H, Tabara Y, Miki T. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke. J Stroke Cerebrovasc Dis 2005;14:67-74.
10. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull 2006;71:45-50.
11. Glueck CJ, Munjal J, Aregawi D, Agloria M, Winiarska M, Khalil Q, Wang P. Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease < or = age 45 years. Transl Res 2007;150:93-100.
12. Tänäsescu R, Ticmeanu M, Nicolau A, Uscätescu V, Cojocaru M, Grecu V, Serbänescu A. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients. Rom J Intern Med 2005;43:79-88.
13. Carod-Artal FJ, Nunes S V, Portugal D, Silva T V, Vargas A P. Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital. Stroke 2005;36:2012-2014.
14. Aznar J, Mira Y, Vayä A, Corella D, Ferrando F, Villa P, Estelles A. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost 2004;91:1031-1034.
15. Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002;33:51-56.
16. Voetsch B, Damasceno B P, Camargo EC, Massaro A, Bacheschi LA, Scaff M, Annichino-Bizzacchi JM, Arruda VR. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000;83:229-233.
17. Levine SR. Hypercoagulable states and stroke: a selective review. CNS Spectr 2005;10:567-578.
18. Triplett DA. Assays for detection of antiphospholipid antibodies. Thromb Haemost 1994;3:281-287.
19. Triplett DA, Barna LK, Unger GA. A hexagonal(II) phase phospholipid neutralization assay for lupus anticoagulant identification. Lupus 1993;70:787-793.
20. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002;70:126-132.
21. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov N P, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich J P, Rosendaal FR, Seligsohn U. Inherited thrombophilia: part 1. Thromb Haemost 1996;76:651-662.
22. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre: Arch Dis Child 1999;81:176-178.
23. Paschóa AF, Guillaumon AT. Impact of screening on thrombophilia for patients with venous thrombosis. Int Angiol 2006;25:52-59.
24. Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32:1793-1799.
25. Cantu C, Alonso E, Jara A, Martínez L, Ríos C, Fernández Mde L, Garcia I, Barinagarrementeria F. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004;35:1790-1794.
26. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Shohab Khan F, Kamal AK. Cerebral venous thrombosis. A descriptive multicenter study of patients in Pakistan and Middle East. Stroke 2008;39:2707-2711.
27. Nadir Y, Hoffman R, Brenner B. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss. Ann Hematol 2007;86:35-40.
28. Ogunyemi D, Cuellar F, Ku W, Arkel Y. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy. Am J Perinatol 2003;20:17-24.
29. Gibson CS, MacLennan AH, Rudzki Z, Hague WM, Haan EA, Sharpe P, Priest K, Chan A, Dekker GA; South Australian Cerebral Palsy Research Group. The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology 2005;37:160-163.
30. Yeh PS, Lin HJ, Li YH, Lin KC, Cheng TJ, Chang CY, Ke DS. Prognosis of young ischemic stroke in Taiwan: impact of prothrombotic genetic polymorphisms. Thromb Haemost 2004;92:583-589.